Kala Bio News and Activities
Presence
Headquarters: United States (USA)
Kala Bio is a company listed under the stock ticker KALA (US).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Kala Bio
- Avi Minkowitz, Chief Executive Officer and Chief Financial Officer
- Hillel Posen, Director
- Yonatan Colman, Director
Popular executive movements at Kala Bio
- Vincent Kosewski, Senior Vice President of Manufacturing and Supply Chain Management, has left the company (posted on October 30 2025).
- Todd Bazemore who was President and Chief Operating Officer, becomes Chief Executive Officer (posted on October 30 2025).
Create your alert
to follow the executive moves at Kala Bio.
Pharmaceuticals
Kala Bio has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Kala Bio
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™ | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Announces Virtual-Only Format for 2020 Annual Meeting of Stockholders | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference | Kala Pharmaceuticals, Inc.
- View more press releases Close
Social media about Kala Bio
- Kala Bio on Wikipedia, Google News & Yahoo Finance
- Kala Bio on LinkedIn, X (Twitter) & YouTube
